Cargando…

Incidence trends of lung and gastroenteropancreatic neuroendocrine neoplasms in Switzerland

The incidence of neuroendocrine neoplasms (NENs) seems to increase worldwide. Long‐term, population‐based series that consider tumor differentiation are, however, sparse. We assessed the incidence trend of lung and gastroenteropancreatic (GEP) NENs according to the latest International Agency for Re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alwan, Heba, La Rosa, Stefano, Andreas Kopp, Peter, Germann, Simon, Maspoli‐Conconi, Manuela, Sempoux, Christine, Bulliard, Jean‐Luc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774736/ https://www.ncbi.nlm.nih.gov/pubmed/33078908 http://dx.doi.org/10.1002/cam4.3524

Ejemplares similares

SUN-302 Incidence Trends in Lung and Gastroenteropancreatic Neuroendocrine Neoplasms
por: Alwan, Heba, et al.
Publicado: (2020)

Incidence trend and conditional survival estimates of gastroenteropancreatic neuroendocrine tumors: A large population‐based study
por: Zhong, Qing, et al.
Publicado: (2018)

Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine‐non‐neuroendocrine neoplasm
por: Zhang, Panpan, et al.
Publicado: (2021)

Site‐specific trends in gastroenteropancreatic neuroendocrine neoplasms in Bavaria, Germany
por: Grundmann, Nina, et al.
Publicado: (2023)

Epidemiologic trends and survival of early-onset gastroenteropancreatic neuroendocrine neoplasms
por: Yao, Hailing, et al.
Publicado: (2023)

Nuclear survivin is a prognosticator in gastroenteropancreatic neuroendocrine neoplasms: a meta-analysis
por: Krieg, Sarah, et al.
Publicado: (2022)

Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms
por: Mafficini, Andrea, et al.
Publicado: (2019)

An update on the diagnosis of gastroenteropancreatic neuroendocrine neoplasms
por: Fang, Jiayun M, et al.
Publicado: (2022)

Advances in the imaging of gastroenteropancreatic neuroendocrine neoplasms
por: Ramachandran, Anupama, et al.
Publicado: (2022)

Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models
por: Kawasaki, Kenta, et al.
Publicado: (2018)

Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot
por: Fernandez, Cornelius J, et al.
Publicado: (2021)

Assessment and State of Nutrition of Patients with Gastroenteropancreatic Neuroendocrine Neoplasms
por: Kikut, Justyna, et al.
Publicado: (2020)

Inflammation-related cytokines and their roles in gastroenteropancreatic neuroendocrine neoplasms
por: Mahečić, Davorka Herman, et al.
Publicado: (2020)

The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms
por: Venizelos, Andreas, et al.
Publicado: (2021)

Update on Epidemiology, Diagnosis, and Biomarkers in Gastroenteropancreatic Neuroendocrine Neoplasms
por: Takayanagi, Daisuke, et al.
Publicado: (2022)

New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
por: Yin, Feng, et al.
Publicado: (2022)

Recent advances in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
por: Dai, Meng, et al.
Publicado: (2022)

Inflammation Related to Obesity in the Etiopathogenesis of Gastroenteropancreatic Neuroendocrine Neoplasms
por: Budek, Marlena, et al.
Publicado: (2022)

Work-Related Factors and Lung Cancer Survival: A Population-Based Study in Switzerland (1990–2014)
por: Bovio, Nicolas, et al.
Publicado: (2022)

Systemic Treatment of Gastroenteropancreatic Neuroendocrine Carcinoma
por: Mollazadegan, Kazhan, et al.
Publicado: (2021)

Therapeutic strategies for gastroenteropancreatic neuroendocrine neoplasms: State-of-the-art and future perspectives
por: Merola, Elettra, et al.
Publicado: (2022)

Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology
por: Kidd, Mark, et al.
Publicado: (2015)

Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms
por: Alexandraki, Krystallenia I., et al.
Publicado: (2017)

Neuroendocrine neoplasms: a brief overview emphasizing gastroenteropancreatic tumors
por: Lopes, José Manuel
Publicado: (2017)

Current status of surgical management of patients with gastroenteropancreatic neuroendocrine neoplasms
por: Stankiewicz, Rafał, et al.
Publicado: (2022)

The Landscape and Clinical Application of the Tumor Microenvironment in Gastroenteropancreatic Neuroendocrine Neoplasms
por: Xu, Shuaishuai, et al.
Publicado: (2022)

Diagnostic work-up and advancement in the diagnosis of gastroenteropancreatic neuroendocrine neoplasms
por: Koffas, Apostolos, et al.
Publicado: (2023)

Estimating 10-year risk of lung and breast cancer by occupation in Switzerland
por: van der Linden, Bernadette Wilhelmina Antonia, et al.
Publicado: (2023)

Epidemiology and classification of gastroenteropancreatic neuroendocrine neoplasms using current coding criteria
por: Sandvik, O. M., et al.
Publicado: (2015)

Minichromosome Maintenance Expression Defines Slow-Growing Gastroenteropancreatic Neuroendocrine Neoplasms()
por: Schimmack, Simon, et al.
Publicado: (2016)

Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms
por: Fang, Cheng, et al.
Publicado: (2017)

Loss of expression and prognosis value of alpha-internexin in gastroenteropancreatic neuroendocrine neoplasm
por: Wang, Yuhong, et al.
Publicado: (2018)

Role of endoscopic submucosal dissection in treatment of rectal gastroenteropancreatic neuroendocrine neoplasms
por: Spychalski, Michał, et al.
Publicado: (2016)

Clinicopathological heterogeneity between primary and metastatic sites of gastroenteropancreatic neuroendocrine neoplasm
por: Shi, Huiying, et al.
Publicado: (2020)

Predictors of antiproliferative effect of lanreotide autogel in advanced gastroenteropancreatic neuroendocrine neoplasms
por: Laskaratos, Faidon-Marios, et al.
Publicado: (2019)

PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3
por: Ali, Abir Salwa, et al.
Publicado: (2020)

Current status of medical treatment for gastroenteropancreatic neuroendocrine neoplasms and future perspectives
por: Hijioka, Susumu, et al.
Publicado: (2021)

Advances in the Diagnosis and Therapeutic Management of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)
por: Kaliszewski, Krzysztof, et al.
Publicado: (2022)

Sarcopenia and Ghrelin System in the Clinical Outcome and Prognosis of Gastroenteropancreatic Neuroendocrine Neoplasms
por: Herrera-Martínez, Yiraldine, et al.
Publicado: (2021)

Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms
por: Canakis, Andrew, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vpko85at9260hktgg538h4pu2v